Paul Hastings LLP are recognised for their capital markets transactions, where they frequently act for public companies, private equity sponsors, venture capital firms and investment banks across a broad range of equity offerings. The group is particularly noted for their expertise in strategic IPOs in the technology and life sciences sectors. The practice is led by Frank Lopez and Colin Diamond in New York, alongside Eric Sibbitt in California, reflecting a cross-coast platform with strong issuer and underwriter-side capabilities. Brandon Bortner focuses on equity financings and debt and hybrid transactions, including convertible securities and restructurings. IPO specialist Seo Salimi is particularly noted for advising financial institutions and life sciences companies on public offerings and related capital markets matters.
Legal 500 Editorial commentary
Key clients
- Smithfield
- Sportradar Group AG
- BofA Securities
- J.P. Morgan
- Xencor, Inc.
- Aardvark Therapeutics, Inc.
- Barclays Capital Inc.
- TD Securities
- Oppenheimer & Co. Inc.
- Goldman Sachs
- Piper Sandler
- Stifel Nicolaus & Company
Work highlights
Advised Smithfield Foods, Inc and its shareholder WH Group Limited, in Smithfield’s $522 million IPO.
Advised Sportradar Group AG in a $517.5 million underwritten secondary public offering by certain selling shareholders. The company concurrently repurchased $65.5 million of its shares. Goldman Sachs & Co. LLC and J.P. Morgan acted as lead book-running managers for the offering.
Represented Xencor, Inc, a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, in its underwritten public offering of $175 million in common stock.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Frank Lopez; Colin Diamond; Eric Sibbitt
Other key lawyers
Brandon Bortner; Seo Salimi